Uric acid–lowering treatment in patients with gout and comorbid conditions
Which kidney comorbidities are an indication to use a uric acid–lowering treatment in gout?
Which kidney comorbidities are an indication to use a uric acid–lowering treatment in gout?
Is the identification of crystals still a gold standard in diagnosing gout or can it be replaced by other modalities (ultrasonography, CT)?
Which foods actually increase/reduce the frequency of attacks in chronic gout?
When to discontinue glucocorticoids in patients with giant cell arteritis (GCA)? How to monitor the disease activity?
In what situations should we perform further investigations in patients with sacral pain? Which patients with sacral pain should have imaging studies performed? How to choose among or what are the indications for radiography, CT, and MRI of the spine, respectively?
When should we urgently qualify a patient with back pain syndrome for surgery?
What management should be considered in patients with Raynaud phenomenon if treatment with calcium channel blockers has been ineffective?
When to introduce pharmacotherapy in patients with Raynaud phenomenon?
Should we perform capillaroscopy in every patient with Raynaud phenomenon?
What is the risk of a systemic connective tissue disease in persons with Raynaud phenomenon? Does the prognostic value of Raynaud phenomenon differ between women and men?